Regulation of Transcriptional Networks by PKC Isozymes: Identification of c-Rel as a Key Transcription Factor for PKC-Regulated Genes

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Garg, Rachana ^a   Caino, M Cecilia ^a   Kazanietz, Marcelo G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN RREB; PROTEIN SRF; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EVI 1; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG; HIVEN86A PROTEIN, HUMAN; ISOENZYME;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INFLAMMATION; PROSTATE CANCER; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; APOPTOSIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; MALE; METABOLISM; PROMOTER REGION; PROSTATE TUMOR; REGULATORY SEQUENCE; TRANSCRIPTION INITIATION; TUMOR CELL CULTURE;

APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; ISOENZYMES; MALE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-REL; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 84879524151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067319     Document Type: Article

References (55)

1. Griner EM, Kazanietz MG, (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nature reviews Cancer 7: 281-294.
2. Newton AC, (1997) Regulation of protein kinase C. Current opinion in cell biology. 9: 161-167.
3. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, et al. (1993) Overexpression of protein kinase C-delta and-epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. The Journal of biological chemistry 268: 6090-6096.
4. Basu A, Sivaprasad U, (2007) Protein kinase Cepsilon makes the life and death decision. Cellular signalling 19: 1633-1642.
5. Caino MC, Lopez-Haber C, Kissil JL, Kazanietz MG, (2012) Non-small cell lung carcinoma cell motility, rac activation and metastatic dissemination are mediated by protein kinase C epsilon. PloS one 7: e31714.
6. Chiu R, Imagawa M, Imbra RJ, Bockoven JR, Karin M, (1987) Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature 329: 648-651.
7. Lee W, Mitchell P, Tjian R, (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49: 741-752.
8. Garg R, Blando J, Perez CJ, Wang H, Benavides FJ, et al. (2012) Activation of Nuclear Factor kappaB (NF-kappaB) in Prostate Cancer Is Mediated by Protein Kinase C {epsilon} (PKC{epsilon}). The Journal of biological chemistry 287: 37570-37582.
9. Satoh A, Gukovskaya AS, Nieto JM, Cheng JH, Gukovsky I, et al. (2004) PKC-delta and-epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells. American journal of physiology Gastrointestinal and liver physiology 287: G582-591.
10. Boyle WJ, Smeal T, Defize LH, Angel P, Woodgett JR, et al. (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64: 573-584.
11. Abou-Kandil A, Chamias R, Huleihel M, Godbey WT, Aboud M, (2012) Differential role of PKC-induced c-Jun in HTLV-1 LTR activation by 12-O-tetradecanoylphorbol-13-acetate in different human T-cell lines. PloS one 7: e29934.
12. Aziz MH, Manoharan HT, Church DR, Dreckschmidt NE, Zhong W, et al. (2007) Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer research 67: 8828-8838.
13. Ng SW, Bakowski D, Nelson C, Mehta R, Almeyda R, et al. (2012) Cysteinyl leukotriene type I receptor desensitization sustains Ca2+-dependent gene expression. Nature 482: 111-115.
14. Yoshida K, Liu H, Miki Y, (2006) Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. The Journal of biological chemistry 281: 5734-5740.
15. Caino MC, von Burstin VA, Lopez-Haber C, Kazanietz MG, (2011) Differential regulation of gene expression by protein kinase C isozymes as determined by genome-wide expression analysis. The Journal of biological chemistry 286: 11254-11264.
16. von Burstin VA, Xiao L, Kazanietz MG, (2010) Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha. Molecular pharmacology 78: 325-332.
17. Fujii T, Garcia-Bermejo ML, Bernabo JL, Caamano J, Ohba M, et al. (2000) Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. The Journal of biological chemistry 275: 7574-7582.
18. Gonzalez-Guerrico AM, Meshki J, Xiao L, Benavides F, Conti CJ, et al. (2005) Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. Journal of biochemistry and molecular biology 38: 639-645.
19. Cornford P, Evans J, Dodson A, Parsons K, Woolfenden A, et al. (1999) Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. The American journal of pathology 154: 137-144.
20. Wang H, Xiao L, Kazanietz MG, (2011) p23/Tmp21 associates with protein kinase Cdelta (PKCdelta) and modulates its apoptotic function. The Journal of biological chemistry 286: 15821-15831.
21. Zhu T, Chen L, Du W, Tsuji T, Chen C, (2010) Synthetic Lethality Induced by Loss of PKC delta and Mutated Ras. Genes & cancer 1: 142-151.
22. Villar J, Arenas MI, MacCarthy CM, Blanquez MJ, Tirado OM, et al. (2007) PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. Cancer research 67: 10859-10868.
23. Gilmore TD, Gerondakis S, (2011) The c-Rel Transcription Factor in Development and Disease. Genes & cancer 2: 695-711.
24. Meshki J, Caino MC, von Burstin VA, Griner E, Kazanietz MG, (2010) Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway. The Journal of biological chemistry 285: 26033-26040.
25. Xiao L, Gonzalez-Guerrico A, Kazanietz MG, (2009) PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens. Molecular carcinogenesis 48: 187-195.
26. Xiao L, Eto M, Kazanietz MG, (2009) ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK. The Journal of biological chemistry 284: 29365-29375.
27. Gonzalez-Guerrico AM, Kazanietz MG, (2005) Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: a key role for protein kinase C delta. The Journal of biological chemistry 280: 38982-38991.
28. Meng Y, Tang W, Dai Y, Wu X, Liu M, et al. (2008) Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Molecular cancer therapeutics 7: 2192-2202.
29. Satomi Y, (2012) Fucoxanthin induces GADD45A expression and G1 arrest with SAPK/JNK activation in LNCap human prostate cancer cells. Anticancer research 32: 807-813.
30. Garg R, Ramchandani AG, Maru GB, (2008) Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin. Carcinogenesis 29: 1249-1257.
31. Diaz-Meco MT, Moscat J, (2012) The atypical PKCs in inflammation: NF-kappaB and beyond. Immunological reviews 246: 154-167.
32. Caino MC, Lopez-Haber C, Kim J, Mochly-Rosen D, Kazanietz MG, (2011) Proteins kinase Cvarepsilon is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes. Oncogene 31: 2593-2600.
33. Wermuth PJ, Addya S, Jimenez SA, (2011) Effect of protein kinase C delta (PKC-delta) inhibition on the transcriptome of normal and systemic sclerosis human dermal fibroblasts in vitro. PloS one 6: e27110.
34. Kunsch C, Ruben SM, Rosen CA, (1992) Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Molecular and cellular biology 12: 4412-4421.
35. Tan TH, Huang GP, Sica A, Ghosh P, Young HA, et al. (1992) Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. Molecular and cellular biology 12: 4067-4075.
36. King KE, Ponnamperuma RM, Allen C, Lu H, Duggal P, et al. (2008) The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth. Cancer research 68: 5122-5131.
37. Belguise K, Sonenshein GE, (2007) PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis. The Journal of clinical investigation 117: 4009-4021.
38. Lessard L, Begin LR, Gleave ME, Mes-Masson AM, Saad F, (2005) Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. British journal of cancer 93: 1019-1023.
39. Mukhopadhyay NK, Ferdinand AS, Mukhopadhyay L, Cinar B, Lutchman M, et al. (2006) Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor. Experimental cell research 312: 3782-3795.
40. Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC, (2002) c-Rel regulation of the cell cycle in primary mouse B lymphocytes. International immunology 14: 905-916.
41. Gugasyan R, Voss A, Varigos G, Thomas T, Grumont RJ, et al. (2004) The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. Molecular and cellular biology 24: 5733-5745.
42. Kenneth NS, Mudie S, Rocha S, (2010) IKK and NF-kappaB-mediated regulation of Claspin impacts on ATR checkpoint function. The EMBO journal 29: 2966-2978.
43. Brodie C, Blumberg PM, (2003) Regulation of cell apoptosis by protein kinase c delta. Apoptosis: an international journal on programmed cell death 8: 19-27.
44. Sumitomo M, Ohba M, Asakuma J, Asano T, Kuroki T, et al. (2002) Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. The Journal of clinical investigation 109: 827-836.
45. Persaud SD, Hoang V, Huang J, Basu A, (2005) Involvement of proteolytic activation of PKCdelta in cisplatin-induced apoptosis in human small cell lung cancer H69 cells. International journal of oncology 27: 149-154.
46. Parthasarathy S, Dhayaparan D, Jayanthi V, Devaraj SN, Devaraj H, (2011) Aberrant expression of epidermal growth factor receptor and its interaction with protein kinase C delta in inflammation associated neoplastic transformation of human esophageal epithelium in high risk populations. Journal of gastroenterology and hepatology 26: 382-390.
47. Loegering DJ, Lennartz MR, (2011) Protein kinase C and toll-like receptor signaling. Enzyme research 2011: 537821.
48. Chen X, Kandasamy K, Srivastava RK, (2003) Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer research 63: 1059-1066.
49. Meyer CF, Wang X, Chang C, Templeton D, Tan TH, (1996) Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. The Journal of biological chemistry 271: 8971-8976.
50. Kharait S, Dhir R, Lauffenburger D, Wells A, (2006) Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochemical and biophysical research communications 343: 848-856.
51. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, et al. (1994) Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. International journal of cancer Journal international du cancer 57: 406-412.
52. Benavides F, Blando J, Perez CJ, Garg R, Conti CJ, et al. (2011) Transgenic overexpression of PKCepsilon in the mouse prostate induces preneoplastic lesions. Cell cycle 10: 268-277.
53. Gonye GE, Chakravarthula P, Schwaber JS, Vadigepalli R, (2007) From promoter analysis to transcriptional regulatory network prediction using PAINT. Methods in molecular biology 408: 49-68.
54. Vadigepalli R, Chakravarthula P, Zak DE, Schwaber JS, Gonye GE, (2003) PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. Omics: a journal of integrative biology 7: 235-252.
55. Gutierrez-Uzquiza A, Arechederra M, Bragado P, Aguirre-Ghiso JA, Porras A, (2012) p38alpha mediates cell survival in response to oxidative stress via induction of antioxidant genes: effect on the p70S6K pathway. The Journal of biological chemistry 287: 2632-2642.